The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 206.50
Bid: 205.00
Ask: 208.00
Change: 1.00 (0.48%)
Spread: 3.00 (1.463%)
Open: 207.00
High: 208.00
Low: 208.00
Prev. Close: 207.00
DATA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update, Dividend Deferral and AGM

21 Apr 2020 07:00

RNS Number : 2610K
GlobalData PLC
21 April 2020
 

21 April 2020

GlobalData Plc

 

COVID-19 Update, Dividend Deferral and AGM

 

GlobalData PLC, the global provider of data, analytics, and insights comments on current trading and the wider impact of the evolving COVID-19 pandemic.

 

COVID-19 Update

 

GlobalData plc (the "Company") continues to closely monitor the evolving COVID-19 (coronavirus) situation and its impact on its business. GlobalData's priority remains the health and safety of our colleagues, our clients and our wider stakeholder group, whilst continuing to operate and provide our clients with real-time data, analytics, and insight that helps them navigate through these uncertain times.

 

As a business, we are following all relevant government guidelines in the countries where we operate and, given the agile and digital nature of our business we have been able to transition smoothly to a 'work from home' model in relatively short order and have not needed to furlough any employees or rely on government support. We recognise that many of our subscription clients are facing real challenges in their markets and are pleased that we have been able to offer a continued service, without any disruption, as well as developing a significant amount of COVID-19 specific content that is giving our clients unique insights into their sectors and geographies, at a time when they need it the most. We have also been active in delivering free Covid-19 content through our news sites, which is helping a wider audience understand their markets and the broader economic and health impacts of the pandemic. The development and deployment of this content has been achieved in a very short time period and is a good demonstration of our agile centralised operating model.

 

For our colleagues, we are actively ensuring that they have a strong and stable digital platform, which enables them to continue to perform in their roles and keep in touch. We are very focused on ensuring that our teams are coping with the challenges that working from home brings and offering the support and flexibility required. We are sending out regular internal communications, including employee surveys focused around well-being, mental health and employee satisfaction, as well as holding regular information sessions to keep our colleagues up to date with company news and initiatives.

 

Together as a business, our colleagues have continued to support our nominated charities for 2020, but we are also pleased to have chosen an additional eight charity partners in our local communities across the globe who are working on specific COVID-19 causes. To date we have raised over £100,000 and we are committed to continue to support our global communities through these difficult times.

 

With a high proportion of recurring revenue and broad sectorial diversification, our business model is resilient and renewal rates have been strong through the first quarter of the current financial year. Over 75% of the Group's revenue derives from recurring subscriptions, so our revenue therefore remains largely unaffected since the onset of the COVID-19 pandemic and we continue to have good visibility for the remainder of the year. As a result of COVID-19, some Events revenue has been deferred into the second half of 2020. Revenue from Events accounts for less than 10% of the Group.

 

Dividend Deferral

 

Although we have a resilient business model, we are aware that we are in unprecedented and very uncertain times. As a management team we are very focused on costs and our cash flow and consequently we have taken measures to scale back our planned sales team recruitment as well as postponing filling a number of open positions. We have a strong balance sheet, with good cash reserves and working capital along with financing arrangements that give us ample liquidity. However, we have taken the decision to delay the payment of the final dividend for the year ended 31 December 2019 by thirty business days to 9 June, which is within sixty business days of the record date of 27 March 2020 to allow us additional time to continue to assess the full impact of COVID-19, as allowed under revised LSE guidance.

 

AGM

 

In light of the COVID-19 outbreak and the enhanced restrictions imposed by the UK Government on 23 March 2020, shareholders will not be permitted to attend our Annual General Meeting, which will be held today at 10.00am, in person. This will safeguard our shareholders' and employees' health. Instead, shareholders can attend the meeting by joining it electronically in accordance with the instructions in the Notice of Meeting. If you are interested in this option, please call 020 7936 6400 in order to make the necessary arrangements.

 

 

ENQUIRIES:

 

GlobalData Plc

 

 

0207 936 6400

Mike Danson, Chief Executive Officer

Graham Lilley, Chief Financial Officer

N+1 Singer

0207 496 3000

James Maxwell

Justin McKeegan

 

Hudson Sandler

0207 796 4133

Nick Lyon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGZGZDNGMGGZM
Date   Source Headline
23rd Apr 20242:44 pmRNSResults of Annual General Meeting
27th Mar 20247:00 amRNSAnnual Report for year ended 31 December 2023
12th Mar 20241:35 pmRNSDirector/PDMR Shareholding
12th Mar 20241:30 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSFull Year Results
1st Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSInvestor and Analyst Seminar
11th Jan 20247:00 amRNSTrading Update & Announcement of Investor Seminar
29th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSInvestment in Healthcare Division by Inflexion
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 202310:48 amRNSDirector/PDMR Shareholding
13th Sep 202310:41 amRNSDirector/PDMR Shareholding
8th Aug 20235:41 pmRNSDirector/PDMR Shareholding
8th Aug 20235:35 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSHalf Year Results
25th Jul 20232:58 pmRNSResults of General Meeting
7th Jul 20237:00 amRNSNotice of General Meeting
30th Jun 202310:00 amRNSDirector/PDMR Shareholding
25th Apr 20233:34 pmRNSResult of AGM
25th Apr 20237:00 amRNSAGM Trading Update and Notice of AI Seminar
29th Mar 20237:00 amRNSNotice of Annual General Meeting 2023
17th Mar 20236:02 pmRNSAnnual Report for year ended 31 December 2022
27th Feb 20237:00 amRNSFull Year Results
27th Jan 20234:31 pmRNSDirector/PDMR Shareholding
27th Jan 20234:26 pmRNSHolding(s) in Company
27th Jan 20239:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSCapital Markets Day
18th Jan 202311:47 amRNSPDMR Dealing
10th Jan 20237:00 amRNSFull year trading update
10th Nov 20224:41 pmRNSSecond Price Monitoring Extn
10th Nov 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20229:44 amRNSHoling(s) in Company
17th Oct 20228:44 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Sep 202210:59 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompletion of TS Lombard Acquisition
15th Aug 20227:00 amRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS£82m Share Scheme Vests for 146 Employees
10th Aug 20227:00 amRNS£410million Debt Financing Facility
1st Aug 20227:00 amRNSHalf Year Results
20th Jul 20227:00 amRNSAppointment of Joint Broker
15th Jul 20227:00 amRNSNotice of Interim Results
28th Jun 202212:45 pmRNSAnnual Report FY2021
26th Apr 202212:32 pmRNSResults of AGM
4th Apr 20221:14 pmRNSNotice of AGM
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.